Japan approves new drug 'donanemab' to treat Alzheimer's disease
Japan's health ministry has officially approved the domestic production and sale of a new drug for Alzheimer's disease. Donanemab was developed by major US pharmaceutical firm Eli Lilly. The ministry gave the greenlight on Tuesday, after a panel of …